E-news April 2024
New! The Brains on Brains Podcast
A career in neuroscience
In this podcast INSERM neuroscientist Anna Beyeler, France, talks to psychiatry resident Ilse Graat, the Netherlands, about the ups and downs of her academic career and what she’s doing to help early career scientists in building their own career.
ECNP Course on ADHD
Register for the e-learnings
Discover the latest insights and cutting-edge developments in ADHD research! Module 4 of the ECNP Course starts on 25 April at 16.00 CEST, with five live online sessions delving into the gut-brain axis in ADHD and immunopsychiatry, iPSC models of ADHD, biomarkers, and the advancement of novel therapeutics.
ECNP Course on Anxiety Disorders
Register for the e-learnings
Explore Anxiety Disorders in Module 4 of the ECNP Course! Starting on 16 May at 16.00 CEST, five live online sessions take you through pharmacological, psychological, neuromodulatory, and virtual reality-based treatments, as well as self-help strategies with mutual aid.
2024 Best Negative Data Prize
Call for submissions
Submit your 'negative' scientific results in preclinical research by 30 April for the Best Negative Data Prize in Preclinical Neuroscience, in collaboration with the Global Preclinical Data Forum (GPDF).
ECNP podcast: PRISM 2 project
Precision medicine for psychiatry
In this episode Abi Abrahams interviews Martien Kas, project co-ordinator, and Hugh Marston, industry lead, as they discuss the legacy of the landmark PRISM 2 project and the transdiagnostic approaches it has pioneered across schizophrenia and Alzheimer’s.
ECNP Workshop Nice
Abstracts are online!
The abstracts of the ECNP Workshop for Early Career Scientists in Europe 2024, showcasing the work of the meeting’s 100 competitively selected early career scientists, are available in the ECNP open access journal Neuroscience Applied.
Free online lecture
New ECNP-PsychX talk
Join Sandra Sanchez-Roige’s talk on ‘Bringing genetics into the clinic: are we there yet?’ on 6 May at 16.30 CEST. She will examine recent psychiatric genetics advancements, focusing on substance use disorders, and explores the distance to achieving precision psychiatry's potential.
ECNP Medicine Chest
Call for applications
The ECNP Medicines Chest, established to facilitate access to clinical-stage drugs for experimental medicine studies, will soon offer a D1 receptor antagonist for clinical use. Read more here and if interested in applying to use the compound in clinical studies, please contact David Nutt via e-mail.
 
Copyright © ECNP 2024
Don’t want to receive our mail anymore? Please click here.
Manage your subscriptions here.
If you can’t read this e-mail,click here
Follow us on